Statistics for Ironwood Pharmaceuticals (id:7653 IRWD)

Valuation metrics

Market cap

563.30M

Enterprise value

1.14B

Trailing P/E (ttm)

59.38

Forward P/E

9.26

PEG ratio

9.26

Price/Sales (ttm)

1.49

Price/Book (mrq)

-1.81

Enterprise Value/Revenue

3.00

Enterprise Value/EBITDA

11.67

Overview

Shares outstanding

160.03M

Float

132.18M

Shares short

10.96M

% Held by insiders

0.02%

% Held by institutions

1.05%

Average volume (10 days)

1.49M

Average volume (90 days)

Price summary

52-Week low

3.51

52-Week high

15.70

52-Week change

-173.01%

Beta

0.48

50-Day moving average

4.27

200-Day moving average

6.85

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

April 02th, 2019

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-0.65%

Operating margin

28.01%

Operational effectiveness

Return on assets

13.05%

Return on equity

289.42%

Income statement

Revenue (ttm)

2.39

Revenue per share (ttm)

2.39

Quarterly revenue growth (yoy)

-0.76

Gross profit (ttm)

0.00

EBITDA

115.11M

Net income to common (ttm)

-2,463,000.00

Diluted EPS (ttm)

-0.01

Quarterly earnings growth (yoy)

-76.20%

Balance sheet

Total cash (mrq)

88.21M

Total cash per share (mrq)

0.55

Total debt (mrq)

614.87M

Total Debt/Equity (mrq)

-1.97

Current ratio (mrq)

361.70%

Book value per share (mrq)

-1.95

Cash flow

Cash flow statement

124.17M

Levered free cash flow (LFCF)

79.68M